Immunogenic detoxified mutants of cholera toxin and of the toxin

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241841, 4242341, 4242401, 4242411, 4242571, 4242611, 435 693, 4351723, A61K 3902, A61K 39108, A61K 39106, C12P 2106

Patent

active

061499196

ABSTRACT:
An immunogenic detoxified protein comprising the amino acid sequence of subunit A of cholera toxin (CT-A) or subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment thereof wherein one or more amino acids at, or in positions corresponding to Val-53, Ser-63, Val-97, Tyr-104 or Pro-106 are replaced with another amino acid or deleted. Examples of specific replacements include Val-53-Asp, Val-53-Glu, Val-53-Tyr, Ser-63-Lys, Val-97-Lys, Val-97-Tyr, Tyr-104-Lys, Tyr-104-Asp, Tyr-104-Ser, Pro-106-Ser. The immunogenic detoxified protein is useful as vaccine for Vibrio cholerae or an enterotoxigenic strain of Escherichia coli and is produced by recombinant DNA means by site-directed mutagenesis.

REFERENCES:
patent: 4666837 (1987-05-01), Harford et al.
patent: 4935364 (1990-06-01), Kaper et al.
Oseashon R. "Cholera", In Plotkin SA, Mortimer EA eds. Vaccines. Philadelphia, WB Saunders Co. 1988.
Pizza et al. Molecular Microbiology 14(1):51-60, 1994.
Lobet et al. Injection and Immunity 59(9):2870-2879, 1991.
Kaslow et al, Vaccine Research 1(1):47-54, 1992.
Burnette, W.N. et al., "Site-Specific Mutagenesis of the Catalytic Subunit of Cholera Toxin: Substituting Lysine for Arginine 7 Causes Loss of Activity", Inf. & Immun., 1991, 59, 4266-4270.
Dallas, W.S. et al., "Cistrons Encoding Escherichia coli Heat-Labile Toxin", J. Bacteriol., 1979, 139, 850-858.
Grant, C.C.R. et al., "Effect of Single Amino Acid Changes on the ADP-Ribosyltransferase Activity of Esherichia coli Heat-Labile Toxin Subunit A", 92nd Gen. Meet. Am. Soc. Microbiol., 1992, Abstract B289, 74.
Harford, S. et al., "Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene", Eur. J. Biochem., 1989, 183, 311-316.
Holmgren, J. et al., "Oral immunization against cholera", Curr. Top. Microbiol. Immunol., 1988, 146, 197-204.
Kaslow, H.R. et al., "Effects of Site-Directed Mutagenesis on Cholera Toxin A1 Subunit ADP-ribosytransferase Activity", 92nd Gen. Meet. Am. Soc. Mictrobiol., 1992, Abstract B291, 74.
Lai, C.Y. et al., "Location and Amino Acid Sequence Around the ADP-Ribosylation Site in the Cholera Toxin Active Subunit A.sub.1 ", Biochem. Biophys. Res. Comm., 1983, 116, 341-348.
Lebacq-Verheyden, A.M. et al., "Posttranslation Processing of Endogenous and of Baculovirus-Expressed Human Gastrin-Relaesing Peptide Precursor", Mol. Cell. Biol., 1988, 8, 3129-3135.
Lobet, Y. et al., "Effect of Site-Directed Mutagenic Alterations on ADP-Ribosyltransferase Activity of the A Subunit of Escherichia coli Heat-Labile Enterotoxin", Inf. & Immun., 1991, 59, 2870-2879.
Lycke, N. et al., "The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked t their ADP-ribosyltransferase activity", Eur. J. Immunol., 1992, 22, 2277-2281.
Mekalanos, J.J. et al., "Cholera toxin genes" nucleotide sequence, deletion analysis and vaccine development, Nature, 1983, 306, 551-557.
Pearson, G.D.N. et al., "Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12", Proc. Natl. Acad. Sci. USA, 1982, 79, 2976-2980.
Pickett, C.L. et al., "Genetics of Type Iia Heat-Labile Enterotoxin of Escherichia coli: Operon Fusions, Nucleotide Sequence, and Hybridization Studies", J. Bacteriol., 1987, 169, 5180-5187.
Sixma, T.K. et al., "Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli", Nature, 1991, 351, 371-377.
Spicer, E.K. et al., "Escherichia coli Heat-Labile Enterotoxin", Biol. Chem., 1982, 257, 5716-5721.
Tsuji, T. et al., "A Single Amino Acid Substitution in the A Subunit of Escherichia coli Enterotoxin Results in a Loss of Its Toxic Activity", J. Biol. Chem., 1990, 265, 22520-22525.
Yamamoto, T. et al., "Primary Structure of Heat-labile Enterotoxin Produced by Escherichia coli Pathogenic for Humans", J. Biol. Chem., 1984, 259, 5037-5044.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunogenic detoxified mutants of cholera toxin and of the toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic detoxified mutants of cholera toxin and of the toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic detoxified mutants of cholera toxin and of the toxin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1254314

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.